Skip to main navigation menu Skip to main content Skip to site footer

Narrative Review

Vol. 8 No. 1 (2004)

Malaria in Pregnancy: an overview

  • Alex C Samak
November 4, 2020




  1. National Center for Infectious Diseases, Division of Parasitic Diseases. Anopheles Mosquitoes. April 23, 2004.
  3. Duffy P, Fried M. Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated
  4. with Increased Birth Weight and the Gestational Age of Newborns. Infec. and Immu. 71(11): 6620-3; 2003
  5. Shulman CE, Graham WJ, Jilo H, et al. Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya. Trans R Soc Trop Med Hyg. 90(5):535-9; 1996
  6. Steketee RW, Wirima JJ, Hightower AW, et al. The effect of malaria and malaria prevention in pregnancy on offspring
  7. birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg. 55(1 Suppl):33-41; 1996
  8. Menendez C, Ordi J, Ismail MR, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis. 181(5):1740-5; 2000.
  9. Ismail MR, Ordi J, Menendez C, et al. Placental pathology in malaria: an histological, immunohistochemical and quantitative study. Human Pathology 31(1):85-93; 2000
  10. McGready R, Davison BB, Stepniewska K, et al. The effects of Plasmodium falciparum and P. vivax infections on placental
  11. histopathology in an area of low malaria transmission. Am J Trop Med Hyg. 70(4):398-407; 2004
  12. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272(5267):1502-4; 1996
  13. Beeson JG, Rogerson SJ, Cooke BM, et al.. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid
  14. in placental malaria. Nat Med. 6(1):86-90; 2000
  15. Fried M, Nosten F, Brockman A, et al. Maternal antibodies block malaria. Nature 395(6705):851-2; 1998
  16. Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with
  17. increased birth weight and the gestational age of newborns. Infect Immun. 71(11):6620-3; 2003
  18. McGregor, I.A. Epidemiology, malaria and pregnancy. Am. J. Trop. Med. Hyg. 33 (4), 517-525; 1984
  19. Rasheed, F.N., Bulmer, J.N., Dun, D.T.,et al. Suppressed peripheral and placental blood lymphoproliferative responses in
  20. first pregnancies: relevance to malaria. Am. J. Trop. Med. Hyg. 48(2):154-60; 1993
  21. Shulman, C. E. , Marshall, T. , Dorman, E. K., et al. Malaria in pregnancy: adverse effects on haemoglobin levels and
  22. birthweight in primigravidae and multigravidae. Tropical Medicine & International Health 6 (10): 770-778; 2001
  23. Cot M, Brutus L, Pinell V, et al.. Malaria prevention during pregnancy in unstable transmission areas: the highlands of
  24. Madagascar. Trop Med Int Health. 7(7):565-72; 2002
  25. Okoko BJ, Enwere G, Ota MO. The epidemiology and consequences of maternal malaria: a review of immunological
  26. basis. Acta Trop. 87(2):193-205; 2003
  27. Newman RD, Hailemariam A, Jimma D, et al. Burden of malaria during pregnancy in areas of stable and unstable
  28. transmission in Ethiopia during a nonepidemic year. J Infect Dis. 187(11):1765-72; 2003
  29. Omodeo-Sale F, Motti A, Basilico N, et al. Accelerated senescence of human erythrocytes cultured with Plasmodium
  30. falciparum. Blood 102(2):705-11; 2003
  31. Steketee RW, Nahlen BL, Parise ME, et al. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med
  32. Hyg. 64(1-2 Suppl):28-35; 2001
  33. Bouyou-Akotet MK, Ionete-Collard DE, Mabika-Manfoumbi M, et al. Prevalence of Plasmodium falciparum infection in
  34. pregnant women in Gabon. Malar J. 2(1):18; 2003
  35. Malhotra M, Sharma JB, Batra S, et al. Maternal and perinatal outcome in varying degrees of anemia. Int J Gynaecol Obstet. 79(2):93-100; 2002
  36. Vassiliadis, S., D. Tsoukatos, I. Athanassakis. Interferoninduced class II expression at the spongiotrophoblastic zone of the murine placenta is linked to fetal rejection and developmental abnormalities. Acta Physiol Scand. 151(4):485;1994
  37. Fried M, Muga R, Misore A, et al. Malaria Elicits Type 1 Cytokines in the Human Placenta:IFN-g and TNF-a Associated
  38. with Pregnancy Outcomes. Jour. of Immunol. 160(5): 2523-30; 1998
  39. Suguitan AL Jr, Leke RG, Fouda G, et al. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis. 188(7):1074-82; 2003
  40. Abrams ET, Brown H, Chensue SW, et al. Host response to malaria during pregnancy: placental monocyte recruitment is
  41. associated with elevated beta chemokine expression. J Immunol. 170(5):2759-64; 2003
  42. Crocker IP, Tanner OM, Myers JE, et al. Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. Placenta 25(4):273-82; 2004
  43. Leopardi O, Naughten W, Salvia L, et al. Malaric placentas. A quantitative study and clinico-pathological correlations. Pathol Res Pract. 192(9):892-8; 1996
  44. LeHesran JY, Cot M, Personne P, et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity
  45. during the first 2 years of life. Am J Epidemiol 146(10):826-31; 1997
  46. Luxemburger C, McGready R, Kham A, et al. Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission. Am J Epidemiol. 154(5):459-65; 2001
  47. Tobian AA, Mehlotra RK, Malhotra I, et al. Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae, and P. ovale in Kenya. J Infect Dis. 182(2):558-63; 2000
  48. Hewson M, Simmer K, Blackmore T. Congenital malaria in a preterm infant. J Paediatr Child Health. 39(9):713-715; 2003
  49. Olowu WA, Torimiro SE. Congenital malaria in 8 hours old newborn: case report. Niger J Med. Apr-11(2):81-2; 2002
  50. Fischer PR. Congenital malaria: an African survey. Clin Pediatr (Phila). 36(7):411-3; 1997
  51. Stoll BJ. The global impact of neonatal infection. Clin Perinatol 1997;24(1):1-21. In: Duffy P. Maternal immunization and
  52. malaria in pregnancy. Vaccine. 2003; 21: 3358-3361.
  53. Okoko BJ, Wesumperuma LH, Ota MO, et al. The influence of placental malaria infection and maternal
  54. hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African
  55. population. J Infect Dis. 184(5):627-32; 2001
  56. Okoko BJ, Wesumperuma LH, Hart AC. Materno-foetal transfer of H. influenzae and pneumococcal antibodies is influenced by prematurity and low birth weight: implications for conjugate vaccine trials. Vaccine 20(5-6):647-50; 2001
  57. Duffy P. Maternal immunization and malaria in pregnancy. Vaccine. 2003; 21(24): 3358-61.
  58. Ismaili J, van der Sande M, Holland MJ, et al. Plasmodium falciparum infection of the placenta affects newborn immune
  59. responses. Clin Exp Immunol. 133(3):414-21; 2003
  60. Steketee RW, Wirima JJ, Bloland PB, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium
  61. falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55(1 Suppl):42-9; 1996
  62. Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in
  63. pregnancy by HIV infection. Lancet 363(9424):1860-7; 2004
  64. Ayisi JG, Branch OH, Rafi-Janajreh A, et al. Does infection with Human Immunodeficiency Virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? J Infect. 46(3):164-72; 2003
  65. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 17(17):2539-41; 2003
  66. Inion I, Mwanyumba F, Gaillard P, et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis. 188(11):1675-8; 2003
  67. Sirima SB, Sawadogo R, Moran AC, et al. Failure of a chloroquine chemoprophylaxis program to adequately prevent
  68. malaria during pregnancy in Koupela District, Burkina Faso. Clin Infect Dis. 36(11):1374-82; 2003
  69. Strategic framework for malaria control during pregnancy in the WHO African Region. Geneva: World Health Organization; 2002.
  70. van Eijk AM, Ayisi JG, ter Kuile FO, et al. Effectiveness of intermittent preventive treatment with sulphadoxinepyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health 9(3):351-60; 2004
  71. Newman RD, Parise ME, Slutsker L, et al. Safety, efficacy and determinants of effectiveness of antimalarial drugs during
  72. pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med
  73. Int Health. 8(6):488-506; 2003
  74. Stoll BJ. The global impact of neonatal infection. Clin Perinatol. 24(1):1-21; 1997
  75. Steketee RW, Wirima JJ, Hightower AW, et al. The effect of malaria and malaria prevention in pregnancy on offspring
  76. birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg. 55(1 Suppl):33-41; 1996
  77. Buffet PA, Gamain B, Scheidig C, et al. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc Natl Acad Sci USA 96(22):12743-8; 1999
  78. Bill C-9 House of Commons. Canada.
  79. Winstanley P, Ward S, Snow R, et al Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clin
  80. Microbiol Rev. 17(3):612-37; 2004
  81. Global Access to Treatment: Canada's Bill C-9 and the Compulsory Licensing of Pharmaceuticals for Export to
  82. Countries in Need. Canadian HIV-AIDS Legal Network. July 2004.


Download data is not yet available.